Lv1
50 积分 2023-06-05 加入
Identification of a EML4-ALK exon 19 fusion variant in lung adenocarcinoma and alectinib resistance
5小时前
已完结
Poor performance status patient with long-lasting major response to pembrolizumab in advanced non-small-cell lung cancer with coexisting POLE mutation and deficient mismatch repair pathway
5天前
已完结
Spatial multi-omics profiling of breast cancer oligo-recurrent lung metastasis
8天前
已完结
Minimal residual disease in colorectal cancer. Tumor-informed versus tumor-agnostic approaches: unraveling the optimal strategy
21天前
已完结
Single-Cell Sequencing Has Revealed the Palmitoylation Landscape in Lung Adenocarcinoma and Identified ABHD17C as a Novel Biomarker
22天前
已完结
Acquired KRAS mutation and loss of low-level MET amplification after durable response to crizotinib in a patient with lung adenocarcinoma
1个月前
已关闭
Use of Oncogene Overlap by Tissue-Based Next-Generation Sequencing to Explore the Mutational Landscape and Survival Impact of HER2, KRAS and MET Copy-Number Gain in Nonsmall Cell Lung Cancer
1个月前
已完结
Receptor Tyrosine Kinase Fusion-Mediated Resistance to EGFR TKI in EGFR-Mutant NSCLC: A Multi-Center Analysis and Literature Review
1个月前
已完结
Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations
1个月前
已完结
皖公网安备34019202002308
